Internal Medicine, Endocrinology, Diabetes, & Metabolism · Greenville, SC
NPI
1174963953
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
877 W Faris Rd Ste D
Greenville, SC, 29605
Phone (864) 455-9031
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,037 services
Medicare patients, 2024
329
Average age 71
Drug cost, 2024
$847K
2,540 prescriptions
Company payments, 2023
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maximilien J Rappaport was code 99214 (office e&m - established), 409 times for 241 patients. In total Maximilien J Rappaport billed 1,037 services in 24 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 409 | 241 | $84.42 | $35K |
| 95251 Test - Miscellaneous | Office | 116 | 44 | $24.41 | $2,831 |
| 83036 Blood Count | Office | 112 | 52 | $9.48 | $1,061 |
| 76536 Ultrasound - Nonspecific | Office | 77 | 73 | $72.94 | $5,617 |
| 99215 Office E&M - Established | Office | 55 | 36 | $117.16 | $6,444 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 53 | 42 | $11.68 | $619 |
| 99204 Office E&M - New | Office | 51 | 51 | $108.19 | $5,518 |
| 99213 Office E&M - Established | Office | 44 | 43 | $58.80 | $2,587 |
| 99205 Office E&M - New | Office | 14 | 14 | $152.52 | $2,135 |
By year: 2022 $64K for 1,116 services; 2023 $58K for 947 services; 2024 $71K for 1,037 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 112 | 52 | $9.48 | $1,061 |
Medicare prescription drug claims, 2024
In 2024, the drug Maximilien J Rappaport prescribed most often to Medicare patients was Levothyroxine Sodium, with 447 prescriptions and refills. In total Maximilien J Rappaport wrote 2,540 Medicare prescriptions that cost $847K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 447 | 1,104 | 121 | $3,662 |
| Methimazole Generic | 195 | 463 | 49 | $2,254 |
| Synthroid Levothyroxine Sodium | 104 | 237 | 22 | $9,486 |
| Hydrocortisone Generic | 97 | 181 | 23 | $5,336 |
| Ozempic Semaglutide | 78 | 142 | 19 | $129K |
| Mounjaro Tirzepatide | 73 | 86 | 17 | $88K |
| Novolog Flexpen Insulin Aspart | 71 | 128 | 21 | $22K |
| Levoxyl Levothyroxine Sodium | 58 | 140 | 15 | $2,336 |
| Metformin Hcl Er Metformin Hcl | 58 | 172 | 21 | $614 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 57 | 85 | 12 | $7,147 |
| Testosterone Cypionate Generic | 51 | 59 | Under 11 | $880 |
| Farxiga Dapagliflozin Propanediol | 49 | 95 | 12 | $51K |
| Tresiba Flextouch U-100 Insulin Degludec | 43 | 94 | 13 | $29K |
| Novolog Insulin Aspart | 38 | 87 | 13 | $17K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 37 | 59 | Under 11 | $47K |
Brand drugs: 1,137 claims; generic drugs: 1,250 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Maximilien J Rappaport $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.